| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.lotuseye.org | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 108.24 Cr. | |
| Earnings per share (EPS) | 0.75 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 68.99 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 202.10 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 25.34 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 2.05 | Calculated using Price: 52.05 |
| Dividend Yield | 0.96 | Period Ending 2020-03 |
| No. of Shares Subscribed | 2.08 Cr. | 20,796,330 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore. Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before. In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision. Lotus has a vision of “empowering eyes to illuminate lives”. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society. Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India. Services offered by the company:
Milestones:
Achievements/ recognition:
|
||
Company Profile
Lotus Eye Care Hospital was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.
Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception
Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.
In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
Lotus has a vision of “empowering eyes to illuminate lives”. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.
Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.
Services offered by the company:
Milestones:
Achievements/ recognition:
| 1 Day |
|
-2.79% |
| 1 Week |
|
+11.21% |
| 1 Month |
|
-0.10% |
| 3 Month |
|
+12.44% |
| 6 Month |
|
+42.94% |
| 1 Year |
|
+73.29% |
| 2 Year |
|
+172.78% |
| 5 Year |
|
+221.27% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | -4.34 | 0.81 | 0.08 | -3.93 | 0.20 | 0.89 | 3.47 | 1.41 | 2.10 | |
| Return on Capital Employed (%) | -4.20 | 0.99 | 0.27 | -4.14 | 0.27 | 1.13 | 3.71 | 1.66 | 3.32 | |
| Return on Assets (%) | -3.96 | 0.73 | 0.07 | -3.45 | 0.18 | 0.81 | 3.12 | 1.25 | 1.88 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 51 | 51 | 51 | 49 | 49 | 50 | 51 | 50 | 51 | |
| Non Curr. Liab. | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | |
| Curr. Liab. | 5 | 5 | 7 | 6 | 5 | 4 | 7 | 6 | 6 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 56 | 57 | 59 | 56 | 55 | 55 | 57 | 56 | 58 | |
| Non Curr. Assets | 52 | 49 | 52 | 51 | 48 | 48 | 49 | 49 | 47 | |
| Curr. Assets | 4 | 7 | 7 | 5 | 6 | 7 | 8 | 7 | 11 | |
| Misc. Exp. not W/O | 0 | 0 | ||||||||
| Total Assets | 56 | 57 | 59 | 56 | 55 | 55 | 57 | 56 | 58 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 26 | 29 | 29 | 30 | 31 | 34 | 38 | 38 | 41 | |
| Other Income | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |
| Total Income | 27 | 30 | 29 | 30 | 32 | 35 | 39 | 39 | 41 | |
| Total Expenditure | -25 | -26 | -26 | -29 | -28 | -31 | -34 | -35 | -37 | |
| PBIDT | 1 | 4 | 3 | 2 | 4 | 4 | 5 | 4 | 5 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | -4 | -3 | -3 | -4 | -4 | -3 | -3 | -3 | -3 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Exceptional Items | 0 | 0 | 0 | 0 | -1 | |||||
| PAT | -2 | 0 | 0 | -2 | 0 | 0 | 2 | 1 | 1 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 2 | 4 | 4 | 2 | 3 | 3 | 6 | 4 | 5 | |
| Cash Fr. Inv. | -3 | -1 | -5 | -5 | -1 | -1 | -4 | -4 | -1 | |
| Cash Fr. Finan. | 0 | 0 | -1 | 2 | -1 | 0 | -2 | -1 | 0 | |
| Net Change | -1 | 2 | -1 | 0 | 2 | 2 | 0 | -1 | 4 | |
| Cash & Cash Eqvt | 0 | 2 | 1 | 1 | 2 | 3 | 4 | 3 | 7 |
|
Mon, 19 Jul 2021
Shareholding for the Period Ended June 30 2021 Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
|
Mon, 19 Jul 2021
Initial Disclosure With Reference To SEBI Circular No SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018. This is to inform you that LOTUS EYE HOSPITAL AND INSTITUTE LIMITED is not identified as Large entity and hence is not required to make the initial disclosure. |
|
Sat, 17 Jul 2021
Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Please Find Enclosed Disclosure Of Related Party Transactions For The Half-Year Ended March 31 2021. Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed disclosure of related party transactions for the half-year ended March 31 2021. |
| Wed, 04 Aug 2021 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Closing Above Previous High
|
Closing Above Previous High For 3 Days
|
Equities
M.F.
Sectors